Literature DB >> 17055024

Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin.

James C Charity1, Ehud Katz, Bernard Moss.   

Abstract

D13 protein trimers, which form an external lattice providing curvature to the membrane of vaccinia virus immature virions, are the target of the drug rifampicin. We obtained 63 rifampicin-resistant mutants following random PCR mutagenesis of the D13L gene and 5 that arose spontaneously. Sequencing indicated that 26 mutants contained a single, unique, amino acid substitution whereas others contained 2 or more. The single mutations, including 6 previously identified, mapped to 24 different amino acids that were distributed over the length of the protein with the majority clustered between amino acids 17 to 33, 222 to 243 and 480 to 488. Two or three different substitutions occurred in six of the 24 amino acids. Representative mutant viruses of each cluster replicated to wild-type levels in the absence of rifampicin and nearly two logs higher than wild-type in the presence of drug. The large number and fitness of the mutations are remarkable in view of the extreme sequence conservation (99-100% amino acid identity amongst all orthopoxviruses). Clustering of mutations could suggest the presence of a rifampicin-binding pocket comprised of discontinuous regions of D13.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055024      PMCID: PMC1817899          DOI: 10.1016/j.virol.2006.09.031

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Common origin of four diverse families of large eukaryotic DNA viruses.

Authors:  L M Iyer; L Aravind; E V Koonin
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Rifampicin prevents virosome localization of L65, an essential vaccinia virus polypeptide.

Authors:  J N Miner; D E Hruby
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

3.  Resistance of vaccinia virus to rifampicin conferred by a single nucleotide substitution near the predicted NH2 terminus of a gene encoding an Mr 62,000 polypeptide.

Authors:  C J Baldick; B Moss
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

4.  Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin.

Authors:  A Nagaya; B G Pogo; S Dales
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

5.  Rifampicin: a specific inhibitor of vaccinia virus assembly.

Authors:  B Moss; E N Rosenblum; E Katz; P M Grimley
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

6.  Vaccinia virus directed RNA and protein synthesis in the presence of rifampicin.

Authors:  B Moss; E Katz; E N Rosenblum
Journal:  Biochem Biophys Res Commun       Date:  1969-08-22       Impact factor: 3.575

7.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

Authors:  D J Jin; C A Gross
Journal:  J Mol Biol       Date:  1988-07-05       Impact factor: 5.469

8.  Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.

Authors:  P M Grimley; E N Rosenblum; S J Mims; B Moss
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

9.  Vaccinia virus rifampicin-resistance locus specifies a late 63,000 Da gene product.

Authors:  J Tartaglia; A Piccini; E Paoletti
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

10.  External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice.

Authors:  Patricia Szajner; Andrea S Weisberg; Jacob Lebowitz; John Heuser; Bernard Moss
Journal:  J Cell Biol       Date:  2005-09-06       Impact factor: 10.539

View more
  16 in total

Review 1.  Poxvirus membrane biogenesis.

Authors:  Bernard Moss
Journal:  Virology       Date:  2015-02-26       Impact factor: 3.616

2.  The structure of a putative scaffolding protein of immature poxvirus particles as determined by electron microscopy suggests similarity with capsid proteins of large icosahedral DNA viruses.

Authors:  Jae-Kyung Hyun; Fasséli Coulibaly; Adrian P Turner; Edward N Baker; Andrew A Mercer; Alok K Mitra
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis.

Authors:  Himani Bisht; Andrea S Weisberg; Patricia Szajner; Bernard Moss
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

4.  Duplication of the A17L locus of vaccinia virus provides an alternate route to rifampin resistance.

Authors:  Karl J Erlandson; Catherine A Cotter; James C Charity; Craig Martens; Elizabeth R Fischer; Stacy M Ricklefs; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

5.  Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin.

Authors:  Damià Garriga; Stephen Headey; Cathy Accurso; Menachem Gunzburg; Martin Scanlon; Fasséli Coulibaly
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-01       Impact factor: 11.205

6.  Vaccinia virus protein F12 associates with intracellular enveloped virions through an interaction with A36.

Authors:  Sara C Johnston; Brian M Ward
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

7.  Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cells.

Authors:  Derek Walsh; Carolina Arias; Cesar Perez; David Halladin; Martin Escandon; Takeshi Ueda; Rie Watanabe-Fukunaga; Rikiro Fukunaga; Ian Mohr
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

8.  Proteomic assessment of humoral immune responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Diane E Grill; Gregory A Poland
Journal:  Vaccine       Date:  2021-12-21       Impact factor: 3.641

Review 9.  Orthopoxvirus targets for the development of new antiviral agents.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Antiviral Res       Date:  2012-03-08       Impact factor: 10.103

10.  Membrane remodeling by the double-barrel scaffolding protein of poxvirus.

Authors:  Jae-Kyung Hyun; Cathy Accurso; Marcel Hijnen; Philipp Schult; Anne Pettikiriarachchi; Alok K Mitra; Fasséli Coulibaly
Journal:  PLoS Pathog       Date:  2011-09-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.